WASHINGTON — White House press secretary Jen Psaki on Tuesday criticized Gov. Ron DeSantis’ demand that the federal government restart the distribution of two types of monoclonal antibodies, saying the Florida Republican is advocating for a treatment that public health officials say is ineffective against the omicron coronavirus variant.

“Let’s just take a step back here just to realize how crazy this is a little bit,” Psaki told reporters. “We’ve approached covid treatments like filling a medicine cabinet. We’re not relying on one type, one brand or treatment. We invested in and continue to buy a variety across monoclonal antibodies, pre-exposure prevention therapies and oral antivirals.”

The Food and Drug Administration on Monday barred health care providers from using monoclonal treatments manufactured by Regeneron and Eli Lilly, a decision that meant the federal government would no longer distribute them across the country. That drew a rebuke from DeSantis, who said the treatments have been important to the state’s response to the coronavirus pandemic in the past.

But Psaki said the federal government had instead provided 71,000 doses of antivirals to Florida over the past month, including 34,000 in the last week, that are effective against omicron. DeSantis and other Florida officials “are still advocating for treatments that don’t work.”

“What the FDA is making clear is that these treatments, the ones that they are fighting over, that the governor is fighting over, do not work against omicron, and they have side effects. That is what the scientists are saying.”

The argument over the monoclonal treatments is the latest showdown between the governor and White House, who have frequently been at odds with each other on issues ranging from immigration to public health precautions related to the pandemic.

DeSantis, who made the drugs a centerpiece of his virus response while resisting vaccine mandates and other safety measures, did not outline how he would fight the FDA decision and it is legally unclear how he would do so. His office did not immediately return an email seeking further clarification. The FDA has sole authority over drug regulation in the United States.

“People have a right to access these treatments, and to revoke it on this basis is just fundamentally wrong and we’re going to fight back,” DeSantis said at a news conference.

As the DeSantis administration rails against the FDA decision to limit use of monoclonal antibody treatments made by Regeneron and Eli Lilly, worth noting both companies say they agree with the feds that these drugs aren’t effective against omicron.

Regeneron left, Lilly right: https://t.co/3QWxqDC4zC pic.twitter.com/3vDj4ojWjm

— Daniel Dale (@ddale8) January 25, 2022

Psaki on Tuesday went a step further with her criticism, linking the governor’s support for the monoclonal treatments to vaccine skeptics and other forms of online misinformation.

“We’ve seen, unfortunately, from the beginning in our pandemic response, a range of steps or pushes that have been made through social media platforms — unfortunately, from the mouths of elected officials advocating for things that don’t work even when we know things do work,” Psaski said. “Injecting disinfectant, promoting other pseudoscience, sowing doubt on the effectiveness of vaccines and boosters, and now promoting treatments that don’t work.

As the DeSantis administration rails against the FDA decision to limit use of monoclonal antibody treatments made by Regeneron and Eli Lilly, worth noting both companies say they agree with the feds that these drugs aren’t effective against omicron.

Regeneron left, Lilly right: https://t.co/3QWxqDC4zC pic.twitter.com/3vDj4ojWjm

— Daniel Dale (@ddale8) January 25, 2022

“We know it works, vaccines and boosters,” the press secretary added. “We have a range of doses of things that do work and treatments, and we’re providing those to Florida.”

---

Copyright ©2025— Trib Total Media, LLC (TribLIVE.com)

---